HLA-G: a shield against inflammatory aggression

被引:163
作者
Carosella, ED [1 ]
Moreau, P [1 ]
Aractingi, S [1 ]
Rouas-Freiss, N [1 ]
机构
[1] Hop St Louis, Inst Univ Hematol, CEA, DSV,DRM,Serv Rech Hematoimmunol, F-75010 Paris, France
关键词
D O I
10.1016/S1471-4906(01)02007-5
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Recent developments in the field of HLA-G research have revealed that, besides its involvement during pregnancy, HLA-G is expressed in peripheral tissues during pathological processes, such as viral infections, malignancies and organ transplantation. Here, we discuss recent findings regarding the influence of HLA-G on the T helper (Th) cytokine balance (favoring Th2-type responses), and the expression of HLA-G during chronic, cutaneous inflammatory diseases, such as psoriasis and atopic dermatitis. We propose a novel role for HLA-G as a tissue-protective molecule in inflammatory responses.
引用
收藏
页码:553 / 555
页数:3
相关论文
共 46 条
  • [1] HLA-G and NK receptor are expressed in psoriatic skin - A possible pathway for regulating infiltrating T cells?
    Aractingi, S
    Briand, N
    Le Danff, C
    Viguier, M
    Bachelez, H
    Michel, L
    Dubertret, L
    Carosella, ED
    [J]. AMERICAN JOURNAL OF PATHOLOGY, 2001, 159 (01) : 71 - 77
  • [2] Primate Mhc-E and -G alleles
    ArnaizVillena, A
    MartinezLaso, J
    Alvarez, M
    Castro, MJ
    Varela, P
    GomezCasado, E
    Suarez, B
    Recio, MJ
    VargasAlarcon, G
    Morales, P
    [J]. IMMUNOGENETICS, 1997, 46 (04) : 251 - 266
  • [3] IL-10 is a key cytokine in psoriasis -: Proof of principle by IL-10 therapy:: A new therapeutic approach
    Asadullah, K
    Sterry, W
    Stephanek, K
    Jasulaitis, D
    Leupold, M
    Audring, H
    Volk, HD
    Döcke, WD
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1998, 101 (04) : 783 - 794
  • [4] HLA-G suppresses proliferation of CD4+ T-lymphocytes
    Bainbridge, DRJ
    Ellis, SA
    Sargent, IL
    [J]. JOURNAL OF REPRODUCTIVE IMMUNOLOGY, 2000, 48 (01) : 17 - 26
  • [5] HLA-G expression: immune privilege for tumour cells?
    Cabestre, FA
    Lefebvre, S
    Moreau, P
    Rouas-Freiss, N
    Dausset, J
    Carosella, ED
    Paul, P
    [J]. SEMINARS IN CANCER BIOLOGY, 1999, 9 (01) : 27 - 36
  • [6] HLA-G and HLA-E: fundamental and pathophysiological aspects
    Carosella, ED
    Paul, P
    Moreau, P
    Rouas-Freiss, N
    [J]. IMMUNOLOGY TODAY, 2000, 21 (11): : 532 - 534
  • [7] Homozygous HLA-G*0105N healthy individuals indicate that membrane-anchored HLA-G1 molecule is not necessary for survival
    Castro, MJ
    Morales, P
    Rojo-Amigo, R
    Martinez-Laso, J
    Allende, L
    Varela, P
    Garcia-Berciano, M
    Guillen-Perales, J
    Arnaiz-Villena, A
    [J]. TISSUE ANTIGENS, 2000, 56 (03): : 232 - 239
  • [8] Soluble HLA-G in human placentas:: Synthesis in trophoblasts and interferon-γ-activated macrophages but not placental fibroblasts
    Chu, WJ
    Fant, ME
    Geraghty, DE
    Hunt, JS
    [J]. HUMAN IMMUNOLOGY, 1998, 59 (07) : 435 - 442
  • [9] Colonna M, 1998, J IMMUNOL, V160, P3096
  • [10] A common inhibitory receptor for major histocompatibility complex class I molecules on human lymphoid and myelomonocytic cells
    Colonna, M
    Navarro, F
    Bellon, T
    Llano, M
    Garcia, P
    Samaridis, J
    Angman, L
    Cella, M
    LopezBotet, M
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1997, 186 (11) : 1809 - 1818